The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 3 , Pages 725-732 , September 2009

Deleted in Malignant Brain Tumors 1 is up-regulated in bacterial endocarditis and binds to components of vegetations

  • Hanna Müller, MD

      Affiliations

    • Division of Neonatology, Department of Pediatrics, University of Heidelberg, Heidelberg, Germany
    • Institute for Vascular Signalling, Centre of Molecular Medicine, Goethe University, Frankfurt/Main, Germany
    • Corresponding Author InformationAddress for reprints: Hanna Müller, MD, Institute for Vascular Signalling, Centre of Molecular Medicine, Goethe University, Theodor Stern Kai 7, 60590 Frankfurt/Main, Germany.
    • ,
  • Marcus Renner, PhD

      Affiliations

    • Division of Molecular Genome Analysis, Deutsches Krebsforschungszentrum, Heidelberg, Germany
    • ,
  • Burkhard M. Helmke, MD

      Affiliations

    • Institute of Pathology, University of Heidelberg, Heidelberg, Germany
    • ,
  • Caroline End, PhD

      Affiliations

    • Division of Molecular Genome Analysis, Deutsches Krebsforschungszentrum, Heidelberg, Germany
    • ,
  • Christel Weiss, PhD

      Affiliations

    • Institute of Medical Statistics and Biomathematics, University Hospital Mannheim, Mannheim, Germany
    • ,
  • Johannes Poeschl, MD

      Affiliations

    • Division of Neonatology, Department of Pediatrics, University of Heidelberg, Heidelberg, Germany
    • ,
  • Jan Mollenhauer, PhD

      Affiliations

    • Division of Molecular Genome Analysis, Deutsches Krebsforschungszentrum, Heidelberg, Germany
    • Molecular Oncology, Medical Biotechnology Center, University of Southern Denmark, Odense, Denmark

Received 9 January 2009 ,Revised 19 April 2009 ,Accepted 20 May 2009.

References 

  1. Bayer AS, Scheld WM. Endocarditis and intravascular infections. In:  Mandell GL,  Bennet JE,  Dolin M editor. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 5th ed. Philadelphia: Churchill Livingstone; 2000;p. 857–902
  2. Veltrop MHAM, Beekhuizen H. Monocytes maintain tissue factor activity after cytolysis of bacteria-infected endothelial cells in an in vitro model of bacterial endocarditis. J Infect Dis. 2002;186:1145–1154
  3. David TE, Gavra G, Feindel CM, Regesta T, Armstrong S, Maganti MD. Surgical treatment of active infective endocarditis: a continued challenge. J Thorac Cardiovasc Surg. 2007;133:144–149
  4. Saito A, Motomura N, Kakimi K, Narui K, Noguchi N, Sasatsu M, et al. Vascular allografts are resistant to methicillin-resistant Staphylococcus aureus through indoleamine 2,3-dioxygenase in a murine model. J Thorac Cardiovasc Surg. 2008;136:159–167
  5. Russell JA. Management of sepsis. N Engl J Med. 2006;355:1699–1713
  6. Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wilgenbus KK, et al. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat Genet. 1997;17:32–39
  7. Holmskov U, Mollenhauer J, Madsen J, Vitved L, Gronlund J, Tornoe I, et al. Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D. Proc Natl Acad Sci U S A. 1999;96:10794–10799
  8. Hikita C, Vijayakumar S, Takito J, Erdjument-Bromage H, Tempst P, Al-Awqati Q. Induction of terminal differentiation in epithelial cells requires polymerization of hensin by galectin 3. J Cell Biol. 2000;151:1235–1246
  9. Mollenhauer J, Herbertz S, Holmskov U, Tolnay M, Krebs I, Merlo A, et al. DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. Cancer Res. 2000;60:1704–1710
  10. Takito J, Al-Awqati Q. Conversion of ES cells to columnar epithelia by hensin and to squamous epithelia by laminin. J Cell Biol. 2004;166:1093–1102
  11. Tino MJ, Wright JR. Glycoprotein-340 binds surfactant protein-A (SP-A) and stimulates alveolar macrophage migration in an SP-A-independent manner. Am J Respir Cell Mol Biol. 1999;20:759–768
  12. Holmskov U, Lawson P, Teisner B, Tornoe I, Willis AC, Morgan C, et al. Isolation and characterization of a new member of the scavenger receptor superfamily, glycoprotein-340 (gp-340), as a lung surfactant protein-D binding molecule. J Biol Chem. 1997;272:13743–13749
  13. Armstrong EA, Ziola B, Habbick BF, Komiyama K. Role of cations and IgA in saliva-mediated aggregation of Pseudomonas aeruginosa in cystic fibrosis patients. J Oral Pathol Med. 1993;22:207–213
  14. Oho T, Yu H, Yamashita Y, Koga T. Binding of salivary glycoprotein-secretory immunoglobulin A complex to the surface protein antigen of Streptococcus mutans. Infect Immun. 1998;66:115–121
  15. Ligtenberg AJM, Bikker FJ, De Blieck-Hogervorst JMA, Veerman ECI, Nieuw Amerongen AV. Binding of salivary agglutinin to IgA. Biochem J. 2004;383:159–164
  16. Boackle RJ, Connor MH, Vesely J. High molecular weight non-immunoglobulin salivary agglutinins (NIA) bind C1Q globular heads and have the potential to activate the first complement component. Mol Immunol. 1993;30:309–319
  17. Müller H, End C, Weiss C, Renner M, Bhandiwad A, Helmke BM, et al. Respiratory Deleted in Malignant Brain Tumours 1 (DMBT1) levels increase during lung maturation and infection. Clin Exp Immunol. 2008;151:123–129
  18. Mollenhauer J, Helmke B, Müller H, Kollender G, Lyer S, Diedrichs L, et al. Sequential changes of the DMBT1 expression and location in normal lung tissue and lung carcinomas. Gene Chromosomes Cancer. 2002;35:164–169
  19. Prakobphol A, Xu F, Hoang VM, Larsson T, Bergstrom J, Johansson I, et al. Salivary agglutinin, which binds Streptococcus mutans and Helicobacter pylori, is the lung scavenger receptor cysteine-rich protein gp-340. J Biol Chem. 2000;275:39860–39863
  20. Bikker FJ, Ligtenberg AJM, Nazmi K, Veerman ECI, van't Hof W, Bolscher JGM, et al. Identification of the bacteria-binding peptide domain on salivary agglutinin (gp-340/DMBT1), a member of the scavenger receptor cysteine-rich superfamily. J Biol Chem. 2002;277:32109–32115
  21. Bikker FJ, Ligtenberg AJ, End C, Renner M, Blaich S, Lyer S, et al. Bacteria binding by DMBT1/SAG/gp-340 is confined to the VEVLXXXXW motif in its scavenger receptor cysteine-rich domains. J Biol Chem. 2004;279:47699–47703
  22. End C, Bikker F, Renner M, Bergmann G, Lyer S, Blaich S, et al. DMBT1 functions as pattern-recognition molecule for poly-sulfated and poly-phosphorylated ligands. Eur J Immunol. 2009;39:833–842
  23. Nagashunmugam T, Malamud D, Davis C, Abrams WR, Friedman HM. Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus. J Infect Dis. 1998;178:1635–1641
  24. Wu T, Golub E, Abrams WR, Malamud D. Gp340 (SAG) binds to the V3 sequence of gp120 important for chemokine receptor interaction. AIDS Res Hum Retroviruses. 2004;20:600–607
  25. Hartshorn KL, White MR, Mogues T, Ligtenberg T, Crouch E, Holmskov U. Lung and salivary scavenger receptor glycoprotein-340 contribute to the host defense against influenza A viruses. Am J Physiol Lung Cell Mol Physiol. 2003;285:L1066–L1076
  26. Mollenhauer J, End C, Renner M, Lyer S, Poustka A. DMBT1 as an archetypal link between infection, inflammation, and cancer. Immunologia. 2007;26:193–209
  27. Bikker FJ, Ligtenberg AJ, van der Wal JE, van den Keijbus PA, Holmskov U, Veerman EC, et al. Immunohistochemical detection of salivary agglutinin/gp-340 in human parotid, submandibular, and labial salivary glands. J Dent Res. 2002;81:134–139
  28. End C, Lyer S, Renner M, Stahl C, Ditzer J, Holloschi A, et al. Generation of a vector system facilitating cloning of DMBT1 variants and recombinant expression of functional full-length DMBT1. Protein Expr Purif. 2005;41:275–286
  29. Sahni A, Francis CW. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood. 2000;96:3772–3778
  30. Ligtenberg AJM, Veerman ECI, Nieuw Amerongen AV, Mollenhauer J. Salivary agglutinin/glycoprotein-340/DMBT1: a single molecule with variable composition and with different functions in infection, inflammation and cancer. Biol Chem. 2007;388:1275–1289
  31. Zinkernagel As, Zinkernagel MS, Elzi MV, Genoni M, Gubler J, Zbinden R, et al. Significance of Staphylococcus lugdunensis bacteremia: report of 28 cases and review of the literature. Infection. 2008;36:314–321
  32. Rosenstiel P, Sina C, End C, Renner M, Lyer S, Till A, et al. Regulation of DMBT1 via NOD2 and TLR4 in intestinal epithelial cells modulates bacterial recognition and invasion. J Immunol. 2007;178:8203–8211
  33. Renner M, Bergmann G, Krebs I, End C, Lyer S, Hilberg F, et al. DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's disease. Gastroenterology. 2007;133:1499–1509
  34. Kerrigan SW, Clarke N, Loughman A, Meade G, Foster TJ, Cox D. Molecular basis for Staphylococcus aureus-mediated platelet aggregate formation under arterial shear in vitro. Arterioscler Thromb Vasc Biol. 2008;28:335–340
  35. Panizzi P, Fiedrich R, Fuentes-Prior P, Richter K, Bock PE, Bode W. Fibrinogen substrate recognition by Staphylocoagulase (pro)thrombin complexes. J Biol Chem. 2006;281:1179–1187
  36. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost. 2005;3:1894–1904
  37. Müller H, End C, Renner M, Helmke BM, Gassler N, Weiss C, et al. Deleted in Malignant Brain Tumors 1 (DMBT1) is present in hyaline membranes and modulates surface tension of surfactant. Respir Res. 2007;8:69
  38. De Lisle RC, Petitt M, Isom KS, Ziemer D. Developmental expression of a mucinlike glycoprotein (MUCLIN) in pancreas and small intestine of CF mice. Am J Physiol. 1998;275(2 Pt 1):G219–G227
  39. Mc Cormick JK, Tripp TJ, Dunny GM, Schlievert PM. Formation of vegetations during infective endocarditis excludes binding of bacterial-specific host antibodies to. Enterococcus faecalis. J Infect Dis. 2002;185:994–997
  40. Sorensen GL, Madsen J, Kejling K, Tornoe I, Nielsen O, Townsend P, et al. Surfactant protein D is proatherogenic in mice. Am J Physiol Heart Circ Physiol. 2006;290:H2286–H2294

 J. Poeschl and J. Mollenhauer contributed equally and should both be considered as senior authors.

 The work was supported by the BMBF Functional Nutritional Research Program grant no. FKZ 0313845 (to J.M.), and the BMBF Program Research Networks for Susceptibility and Resistance to Infection: PROGRESS-consortium grant no. FKZ 01KI07115 (to J.M.).

PII: S0022-5223(09)00761-2

doi: 10.1016/j.jtcvs.2009.05.021

The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 3 , Pages 725-732 , September 2009

Article Tools

* Image Usage & Resolution